Literature DB >> 24256547

Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine.

Fumitaka Ogura1, Shohei Wakao, Yasumasa Kuroda, Kenichiro Tsuchiyama, Mozhdeh Bagheri, Saleh Heneidi, Gregorio Chazenbalk, Setsuya Aiba, Mari Dezawa.   

Abstract

In this study, we demonstrate that a small population of pluripotent stem cells, termed adipose multilineage-differentiating stress-enduring (adipose-Muse) cells, exist in adult human adipose tissue and adipose-derived mesenchymal stem cells (adipose-MSCs). They can be identified as cells positive for both MSC markers (CD105 and CD90) and human pluripotent stem cell marker SSEA-3. They intrinsically retain lineage plasticity and the ability to self-renew. They spontaneously generate cells representative of all three germ layers from a single cell and successfully differentiate into targeted cells by cytokine induction. Cells other than adipose-Muse cells exist in adipose-MSCs, however, do not exhibit these properties and are unable to cross the boundaries from mesodermal to ectodermal or endodermal lineages even under cytokine inductions. Importantly, adipose-Muse cells demonstrate low telomerase activity and transplants do not promote teratogenesis in vivo. When compared with bone marrow (BM)- and dermal-Muse cells, adipose-Muse cells have the tendency to exhibit higher expression in mesodermal lineage markers, while BM- and dermal-Muse cells were generally higher in those of ectodermal and endodermal lineages. Adipose-Muse cells distinguish themselves as both easily obtainable and versatile in their capacity for differentiation, while low telomerase activity and lack of teratoma formation make these cells a practical cell source for potential stem cell therapies. Further, they will promote the effectiveness of currently performed adipose-MSC transplantation, particularly for ectodermal and endodermal tissues where transplanted cells need to differentiate across the lineage from mesodermal to ectodermal or endodermal in order to replenish lost cells for tissue repair.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24256547     DOI: 10.1089/scd.2013.0473

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  60 in total

1.  Therapeutic Potential of Adipose-Derived SSEA-3-Positive Muse Cells for Treating Diabetic Skin Ulcers.

Authors:  Kahori Kinoshita; Shinichiro Kuno; Hisako Ishimine; Noriyuki Aoi; Kazuhide Mineda; Harunosuke Kato; Kentaro Doi; Koji Kanayama; Jingwei Feng; Takanobu Mashiko; Akira Kurisaki; Kotaro Yoshimura
Journal:  Stem Cells Transl Med       Date:  2015-01-05       Impact factor: 6.940

2.  Very small embryonic-like stem cells: a scientific debate?

Authors:  Graham C Parker
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

Review 3.  Adipose-Derived Stem Cell Delivery for Adipose Tissue Engineering: Current Status and Potential Applications in a Tissue Engineering Chamber Model.

Authors:  Weiqing Zhan; Shaun S Tan; Feng Lu
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

4.  Association of adiposity, telomere length and mortality: data from the NHANES 1999-2002.

Authors:  J A Batsis; T A Mackenzie; E Vasquez; C M Germain; R T Emeny; P Rippberger; F Lopez-Jimenez; S J Bartels
Journal:  Int J Obes (Lond)       Date:  2017-08-16       Impact factor: 5.095

Review 5.  The Science of Fat Grafting.

Authors:  Linden Shih; Matthew J Davis; Sebastian J Winocour
Journal:  Semin Plast Surg       Date:  2020-02-15       Impact factor: 2.314

6.  Adipose stromal/stem cells in regenerative medicine: Potentials and limitations.

Authors:  Leandra Santos Baptista
Journal:  World J Stem Cells       Date:  2020-01-26       Impact factor: 5.326

Review 7.  Stem cell therapy: old challenges and new solutions.

Authors:  Carmela Rita Balistreri; Elena De Falco; Antonella Bordin; Olga Maslova; Alexander Koliada; Alexander Vaiserman
Journal:  Mol Biol Rep       Date:  2020-03-03       Impact factor: 2.316

Review 8.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 9.  Hyaluronic Acid (HA) Scaffolds and Multipotent Stromal Cells (MSCs) in Regenerative Medicine.

Authors:  Elena Dai Prè; Giamaica Conti; Andrea Sbarbati
Journal:  Stem Cell Rev Rep       Date:  2016-12       Impact factor: 5.739

10.  The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model.

Authors:  Masahiro Iseki; Masamichi Mizuma; Shohei Wakao; Yoshihiro Kushida; Katsuyoshi Kudo; Masahiko Fukase; Masaharu Ishida; Tomoyuki Ono; Mitsuhiro Shimura; Ichiro Ise; Yukie Suzuki; Teruko Sueta; Ryuta Asada; Shinobu Shimizu; Yoshiyuki Ueno; Mari Dezawa; Michiaki Unno
Journal:  Surg Today       Date:  2020-09-11       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.